Status: current, Defined. Date: 31-May 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1902561000168112 | carbidopa 12.5 mg + entacapone 200 mg + levodopa 50 mg tablet, 250 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1902571000168118 | levodopa 50 mg + carbidopa 12.5 mg + entacapone 200 mg tablet, 250 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| levodopa 50 mg + carbidopa 12.5 mg + entacapone 200 mg tablet, 250 | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| levodopa 50 mg + carbidopa 12.5 mg + entacapone 200 mg tablet, 250 | has MPUU | levodopa 50 mg + carbidopa 12.5 mg + entacapone 200 mg tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Stalevo 50/12.5/200 tablet, 250 | Is a | True | levodopa 50 mg + carbidopa 12.5 mg + entacapone 200 mg tablet, 250 | Inferred relationship | Some | |
| Lecteva 50/12.5/200 tablet, 250 | Is a | True | levodopa 50 mg + carbidopa 12.5 mg + entacapone 200 mg tablet, 250 | Inferred relationship | Some | |
| L.C.E. 50/12.5/200 tablet, 250 | Is a | True | levodopa 50 mg + carbidopa 12.5 mg + entacapone 200 mg tablet, 250 | Inferred relationship | Some | |
| Centevo 50/12.5/200 mg tablet, 250 | Is a | True | levodopa 50 mg + carbidopa 12.5 mg + entacapone 200 mg tablet, 250 | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR